4.33
0.66 (17.98%)
0.66 (17.98%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.66 | 17.98% | 4.33 | 15:03:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.78 | 4.05 | 4.78 | 3.67 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.26 | 4.33 | 0.07 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,886 | 2,473,078 | $ 4.44 | $ 10,977,532 | 1,343,419 | 1.08 - 7.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:03:01 | 200 | $ 4.33 | USD |
Acer Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 59.29M | 13.92M | 9.12M | $ - | $ - | -2.91 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.76 | 4.78 | 3.33 | 4.14 | 1,903,033 | 0.57 | 15.16% |
| 1 Month | 2.61 | 4.78 | 2.40 | 3.64 | 2,034,041 | 1.72 | 65.9% |
| 3 Months | 2.46 | 4.78 | 2.30 | 3.51 | 765,322 | 1.87 | 76.02% |
| 6 Months | 3.65 | 5.84 | 2.15 | 3.62 | 553,458 | 0.68 | 18.63% |
| 1 Year | 4.11 | 7.25 | 1.08 | 3.57 | 350,864 | 0.22 | 5.35% |
| 3 Years | 18.849 | 34.10 | 1.08 | 5.51 | 169,315 | -14.52 | -77.03% |
| 5 Years | 8.55 | 34.10 | 1.08 | 5.72 | 155,236 | -4.22 | -49.36% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
